In the ImmuCellAI database, within the realm of pan-cancer, RBFOX2 exhibited a negative correlation with the gamma delta T cells, NK cells, and CD8+ T cells in pan-cancer (Figure 4B). This evidence concerns the gene CD8A and cancer.